← All organizations

Amarantus BioScience Holdings, Inc.

For profitWebsite ↗

Highest phase reached

Phase 2

First clinical trial

Aug 1, 2011

Last known activity

Sep 1, 2016

Acquired by Avant ImmunotherapeuticsCelldex Therapeutics on Mar 1, 2016

Timeline

2000s

  1. Jan 1, 2008

    Amarantus BioScience Holdings, Inc.— Founded

  2. Jan 1, 2008

    Celldex Therapeutics— Now

2010s

  1. Mar 1, 2016

    Avant Immunotherapeutics— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Recent trials (4)

Details

Founded
New York, NY, US Jan 1, 2008
Last known activity
Sep 1, 2016